tramadol has been researched along with Peripheral Nerve Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alsalem, M; Barakat, NA; El-Salem, K; Haddad, M; Jaffal, SM; Saleh, T | 1 |
| Boonchaya-Anant, P; Ganokroj, P | 1 |
| Chang, S; Mehta, V; Ramaswamy, S | 1 |
| Egashira, N; Higuchi, H; Kaname, T; Kawashiri, T; Shirahama, M; Tsutsumi, K; Ushio, S; Yamamoto, S | 1 |
| Fujiwara, K; Hasegawa, K; Kurosaki, A; Nishikawa, T; Sato, S; Shintani, D; Yabuno, A; Yano, Y; Yoshida, H | 1 |
| Backonja, M; Froman, S; Ho, TW; Leibensperger, H; Ma, J; Polydefkis, M | 1 |
| Liu, YC; Wang, WS | 1 |
| Dost, R; Rostock, A; Rundfeldt, C | 1 |
| Hama, A; Sagen, J | 1 |
| Apaydin, S; Guneli, E; Karabay Yavasoglu, NU; Uyar, M | 1 |
| Haslam, C; Nurmikko, T | 1 |
1 trial(s) available for tramadol and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies.
Topics: Adolescent; Adult; Amines; Analgesics; Cross-Over Studies; Cyclohexanecarboxylic Acids; Diphenhydramine; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Single-Blind Method; Sleep Wake Disorders; Tramadol; Young Adult | 2009 |
10 other study(ies) available for tramadol and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Interaction of the synthetic cannabinoid WIN55212 with tramadol on nociceptive thresholds and core body temperature in a chemotherapy-induced peripheral neuropathy pain model.
Topics: Analgesics; Animals; Antineoplastic Agents; Body Temperature; Calcium; Cannabinoids; Capsaicin; Ganglia, Spinal; Male; Nociception; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Tramadol | 2023 |
Diabetic muscle infarction: rare complication with a distinct clinical manifestation.
Topics: Analgesics, Opioid; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Humans; Hypoglycemic Agents; Infarction; Insulin; Magnetic Resonance Imaging; Muscle, Skeletal; Peripheral Nervous System Diseases; Tramadol; Treatment Outcome; Ultrasonography; Young Adult | 2019 |
Tapentadol--the evidence so far.
Topics: Analgesics, Opioid; Clinical Trials as Topic; Evidence-Based Medicine; Guidelines as Topic; Humans; Peripheral Nervous System Diseases; Phenols; Tapentadol; Tramadol | 2015 |
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Topics: Administration, Ophthalmic; Analgesics; Animals; Antineoplastic Agents; Axons; Bortezomib; Duloxetine Hydrochloride; Hyperalgesia; Mexiletine; Nerve Degeneration; Neurites; PC12 Cells; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tramadol | 2015 |
[Combination Therapy of Pregabalin with Tramadol for Treatment of Peripheral Neuropathy in Patients with Gynecological Cancer Receiving Taxane Containing Chemotherapy].
Topics: Adult; Aged; Drug Combinations; Female; Humans; Middle Aged; Ovarian Neoplasms; Peripheral Nervous System Diseases; Pregabalin; Retrospective Studies; Taxoids; Tramadol; Uterine Neoplasms | 2017 |
Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.
Topics: Acetaminophen; Adult; Aged; Analgesics; Antineoplastic Agents; Drug Combinations; Female; Genotype; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Polymorphism, Genetic; Receptors, Opioid, mu; Tramadol | 2012 |
The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Topics: Acute Disease; Amines; Analgesics, Opioid; Animals; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Indoles; Ion Channel Gating; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Peripheral Nervous System Diseases; Phenylenediamines; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Wistar; Spinal Nerves; Touch; Tramadol | 2004 |
Altered antinociceptive efficacy of tramadol over time in rats with painful peripheral neuropathy.
Topics: Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Time Factors; Tramadol; Yohimbine | 2007 |
Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Behavior, Animal; Constriction, Pathologic; Dexmedetomidine; Drug Combinations; Hot Temperature; Hyperalgesia; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Postural Balance; Rats; Rats, Wistar; Reaction Time; Sciatica; Time Factors; Tramadol | 2007 |
Pharmacological treatment of neuropathic pain in older persons.
Topics: Aged; Amines; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Osteoarthritis; Pain; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Tramadol | 2008 |